Light Chain Cast Nephropathy in Myeloma Patients

More Information

Trial Status

Accepting patients

Enrollment

450 patients (estimated)

Sponsors

BlossomHill Therapeutics, Brigham and Women's Hospital

Collaborators

Thomas Jefferson University Hospital, University of New Mexico, University of Colorado Health, Texas Medical Center, Ochsner Health System, Fred Hutchinson Cancer Research Center, University of Virginia, University of Pittsburgh, University of Pennsylvania, University of Minnesota - Masonic Cancer Center, University of Chicago, UCLA Jonsson Comprehensive Cancer Center, University of Alabama at Birmingham, Stanford University Cancer Institute (Palo Alto), Ohio State University Comprehensive Cancer Center, Northwell Health, Icahn School of Medicine at Mount Sinai, Moffitt Cancer Center, Medical University of South Carolina, MD Anderson Cancer Center, Mayo Clinic, Massachusetts General Hospital, Dana-Farber Cancer Institute, Boston Medical Center, Baystate Health, Janssen Pharmaceuticals

Trial Type

Observational

Last Update

4 months ago

SparkCures ID

1966

NCT Identifier

NCT06483139